Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke

NCT01464307 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-stroke Spasticity of the Lower Limb

Interventions

DRUG: IncobotulinumtoxinA (400 Units)
DRUG: Placebo Comparator

Sponsor

Merz Pharmaceuticals GmbH